NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

Search

Coloplast A-S (Class B)

Fechado

442 1.1

Visão Geral

Variação de preço das ações

24h

Atual

Mín

437

Máximo

446.9

Indicadores-chave

By Trading Economics

Rendimento

522M

1.4B

Vendas

83M

7B

P/E

Médio do Setor

24.901

56.063

EPS

6.32

Rendimento de Dividendos

5.27

Margem de lucro

19.835

Funcionários

16,983

EBITDA

309M

2.3B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.27%

2.45%

Próximos Ganhos

12 de mai. de 2026

Próxima data de dividendos

20 de mai. de 2026

Próxima data de ex-dividendo

18 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-19B

99B

Abertura anterior

440.9

Fecho anterior

442

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

1 de abr. de 2026, 22:56 UTC

Notícias Principais

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

1 de abr. de 2026, 20:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

1 de abr. de 2026, 23:55 UTC

Conversa de Mercado

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

1 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

1 de abr. de 2026, 23:23 UTC

Notícias Principais

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

1 de abr. de 2026, 23:07 UTC

Ganhos

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

1 de abr. de 2026, 23:02 UTC

Notícias Principais

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

1 de abr. de 2026, 23:00 UTC

Notícias Principais

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

1 de abr. de 2026, 23:00 UTC

Notícias Principais

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

1 de abr. de 2026, 23:00 UTC

Notícias Principais

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

1 de abr. de 2026, 22:39 UTC

Ganhos

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

1 de abr. de 2026, 22:08 UTC

Conversa de Mercado

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

1 de abr. de 2026, 22:00 UTC

Notícias Principais

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

1 de abr. de 2026, 22:00 UTC

Notícias Principais

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

1 de abr. de 2026, 21:56 UTC

Aquisições, Fusões, Aquisições de Empresas

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

1 de abr. de 2026, 21:31 UTC

Notícias Principais

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

1 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

1 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

1 de abr. de 2026, 20:38 UTC

Ganhos

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

1 de abr. de 2026, 20:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

1 de abr. de 2026, 20:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

1 de abr. de 2026, 20:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

1 de abr. de 2026, 20:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Extends Tender Offer To Acquire Arcellx >GILD

1 de abr. de 2026, 20:07 UTC

Conversa de Mercado

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

1 de abr. de 2026, 20:07 UTC

Aquisições, Fusões, Aquisições de Empresas

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat